CerilliantLog In | Recently Purchased | Favorites | My COAs | Cart (0)Cerilliant ISO


22-September-2015
Introducing the latest antiviral / antiretroviral Certified Spiking Solution® from Cerilliant — Lamivudine. 

Lamivudine, 1.0 mg/mL, 1 mL L-037
1.0 mg/mL in Methanol

Lamivudine, marketed under trade names such as Epivir® and Epivir-HBV®, is a nucleoside analog reverse-transcriptase inhibitor (NRTI) used for the treatment of human immunodeficiency virus (HIV) and hepatitis B. Therapeutic drug monitoring (TDM) of lamivudine concentrations in patient serum is performed to evaluate toxicity, guide dosing regimens, and avoid adverse drug-drug interactions. This Certified Spiking Solution® is suitable for use as starting material in the preparation of calibrators, controls, or linearity standards for a variety of LC-MS/MS or GC/MS lamivudine testing applications.



Cerilliant Certified Solution Standards and Certified Spiking Solutions are manufactured to the highest industry standards. We are accredited to ISO Guide 34 and ISO/IEC 17025 & certified to ISO 13485 and ISO 9001. Our quality system also incorporates cGMP and GLP requirements


All New Product Announcements


© 2018 Cerilliant Corporation | 811 Paloma Drive, Suite A | Round Rock, Texas 78665
Sigma-Aldrich is a subsidiary of Merck KGaA, Darmstadt, Germany
Products | News/Events | Sitemap | Privacy Policy | EHS Policy | Terms & Conditions | Contact
Follow Us: Cerilliant Linkedin LinkedIn